Immune cell targeting innovation creating infrastructure — C-C chemokine receptor (CCR) targeted therapies blocking inflammatory cell recruitment supporting treatment of inflammatory and autoimmune conditions, establishing CCR targeting as emerging immunotherapy infrastructure, with the C-C Chemokine Receptor Market experiencing expansion driven by inflammatory disease burden, immune...